Award Winner (Martin VanTrieste Pharmaceutical Science Award) 2023: Andrew Chang, PhD
Back to Honor Awards PageAbout Andrew Chang, PhD
Dr. Andrew Chang is a multifaceted quality and CMC leader with 25 years well-rounded medical product regulatory and industry experiences. He is the chair for PDA Biopharmaceutical Advisory Board (BioAB) and a board of director for CASSS-Sharing Science Solutions. At his current capacity as a Vice President, Quality and Regulatory Compliance, Regulatory Policy and Intelligence, Global Regulatory Affairs, Novo Nordisk, he provides strategic leadership on Regulatory and Quality related Policy, External Affairs, strategic advice and solutions to quality and regulatory related challenges.
Chang is a multifaceted quality and CMC leader with 28 years of experience in medical product regulation. Chang is the chair for the BioAB at the PDA and a Board of Director for PDA and CASSS-Sharing Science Solutions. In Chang's current role as a Vice President of Quality and Regulatory Compliance, Regulatory Policy and Intelligence and Global Regulatory Affairs at Novo Nordisk, he provides strategic leadership on regulatory and quality related policy, external Affairs, strategic advice and solutions to quality and regulatory-related challenges.
Martin VanTrieste Pharmaceutical Science Award
